are taken for cortisol assay before and 30 minutes after the intramuscular injection of ACTH. Adequate adrenal reserve is revealed by a prompt increase in plasma cortisol, whereas adrenal insufficiency is associated with a subnormal response. This screening of patients can be done quickly, as an out-patient procedure, requires only two small blood samples and the result, if necessary, can be available within one hour. By contrast, the more usual urinary studies require in-patient admission for several days, accurate urine saves, considerable technical effort, and the result may not be available for a week or longer.
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Plasma assays may also be employed in the investigation of hypopituitarism (Landon et ai, 1963) and adrenal hyperfunction (James et ai, 1965) , and the assay of plasma cortisol is thus a useful laboratory procedure which in many cases can replace urinary steroid determinations.
R. V. BROOKS
In the normal subject the secretion of cortisol and the androgens is dependent upon stimulation another hormone, corticotrophin releasing factor (CRF), produced by the hypothalamus (Fig. 1) . The release of CRF is itself governed by two mechanisms:
1. By the concentration of cortisol circulating in the blood; a high concentration of cortisol in the blood inhibits the secretion of CRF which, in turn diminishes the secretion of ACTH, cortisol and the androgens. There is therefore a self-regulating mechanism by which the level of cortisol in the blood tends to be kept constant.
2. Superimposed on this self-regulating mechanism there is a second mechanism by which various stimuli, e.g. cold, injury, surgical operation, infection and mental stress, cause the release of increased amounts of CRF from the hypothalamus. These nervous influences result in the concentration of cortisol being raised above the normal self-regulating level.
ACTHtests
The ability of the adrenal to respond to stimulation can be tested by administering ACTH isolated from the pituitary glands of animals and measuring the response in steroid production. In one form of this test the urinary 17-hydroxycorticosteroids (17-0HCS) are measured during two control days and for four days while receiving 20 units of ACTH gel every 12 hours. Normal subjects respond with a 3-7 fold increase in 17-0HCS and patients with hypopituitarism who have initially low levels of urinary l7-0HCS may show an even bigger percentage increase. In Addison's disease, however, where the primary defect is in the adrenal gland, no increase is obtained.
Metopirone test
The ability of the pituitary to produce increased amounts of ACTH can be tested with metopirone, a substance which interferes with the final stage of cortisol synthesis. The block in the synthesis of cortisol means that the blood levels of cortisol will tend to be low and therefore the inhibitory effect on the hypothalamus will be removed. In the normal subject the release of CRF and ACTH will therefore be increased and result in the increased secretion of the precursors of cortisol. ll-Deoxycortisol, the 45 immediate precursor of cortisol, is secreted in large amount and its metabolites may be measured in the urine as l7-0HCS. The normal subject therefore responds to metopirone treatment (1 g. t.d.s. for 3 days) by increasing the excretion of 17-0HCS. The patient with hypopituitarism is unable to respond in this way and the urinary l7-0HCS do not increase.
Dexamethasone test
This is used in the investigation of adrenocortical hyperactivity. If cortisol is administered to a normal subject the release of CRF, ACTH and endogenous cortisol is inhibited. It is however difficult to demonstrate this inhibition because the administered cortisol is also metabolised to urinary l7-OHCS. By using dexamethasone, a potent synthetic glucocorticoid, it is possible to suppress endogenous secretion by normal subjects using doses (0'5 mg. 6 hourly) too small to interfere with the urinary 17-0HCS which therefore fall to a very low level. Patients with Cushing's syndrome are not suppressed by this dose. Larger doses of 1·5 or 2 mg. 6 hourly will usually suppress the l7-0HCS when the hyperactivity is due to hyperplasia but not when an adrenal tumour is the cause.
